Vivak Parkash - <institution>York Biomedical Research Institute, Hull York Medical School, University of York</institution>, York, <country>UK</country>

基本信息

Career Trajectory

Bio

Dual role: Clinical Research Fellow at the University of York, working on a controlled human infection model for cutaneous leishmaniasis; Infectious Diseases & General internal medicine doctor at Sheffield Teaching Hospitals NHS Foundation Trust.

Research Interests

Papers共 20 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Safety, effectiveness, and skin immune response in a controlled human infection model of sand fly transmitted cutaneous leishmaniasis

Vivak Parkash,Helen Ashwin,Shoumit Dey,Jovana Sadlova,Barbora Vojtkova,Katrien Van Bocxlaer,Rebecca Wiggins, David Thompson,Nidhi Sharma Dey,Charles L. Jaffe,Eli Schwartz,Petr Volf,Charles J. N. Lacey,Alison M. Layton,Paul M. Kaye

crossref（2024）

Cited0Views0Bibtex

Development of a Core Outcome Measure Instrument; "leishcom_lcl", for Localised Cutaneous Leishmaniasis

Shalindra Ranasinghe,Sujai Senarathne,Vijani Somaratne,Charles J. N. Lacey,Surangi Jayakody, Amila Wickramasinghe,Indira Kahawita,Hiro Goto,Mitali Chatterjee,Jose A. L. Lindoso,Vivak Parkash, Surya J. Chaudhuri,Renu Wickremasinghe,Nilay K. Das,Paul M. Kaye,Alison M. Layton

PLoS Neglected Tropical Diseasesno. 8 (2024): e0012393

Cited0Views0WOSBibtex

Safety and Reactogenicity of a Controlled Human Infection Model of Sand Fly-Transmitted Cutaneous Leishmaniasis

NATURE MEDICINE (2024)

Cited0Views0WOSNATUREBibtex

GD03 Identifying Core Outcome Domains and Development of a Cutaneous Leishmaniasis Core Outcome Measure for Use in Clinical Practice and Trials

Sujai Senarathne,Shalindra Ranasinghe,Indira Kahawita,Vijani Somaratne, Amila Wickramasinghe,Vivak Parkash,Charles Lacey,Paul Kaye,Alison Layton

BRITISH JOURNAL OF DERMATOLOGY (2023)

Cited0Views0Bibtex

Outpatient Parenteral Antimicrobial Therapy for Leishmaniasis: 13 Years' Experience at a Large UK Infectious Diseases Centre

Vivak Parkash,Nicholas Laundy,Oyewole Christopher Durojaiye

TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE（2023）

Cited1Views0WOSBibtex

37 Pathway to a Controlled Human Infection Model for Leishmania Major

Vivak Parkash,Helen Ashwin,Georgina Jones,Jovana Sadlova,Barbora Vojtkova,Charles Jaffe,Petr Volf,Alison Layton,Paul Kaye,Charles Lacey

Clinical Infection in Practice（2022）

Cited0Views0Bibtex

Patterns of Thromboembolic Pulmonary Vascular Disease in COVID-19

Yousef Shahin,Smitha Rajaram,Vivak Parkash,James M. Wild,David G. Kiely,Andrew J. Swift

PULMONARY CIRCULATION（2021）

Cited6Views0WOSBibtex

Overcoming Roadblocks in the Development of Vaccines for Leishmaniasis

Paul M. Kaye,Sakshi Mohan,Carsten Mantel,Melissa Malhame,Paul Revill,Epke Le Rutte,Vivak Parkash,Alison M. Layton,Charles J. N. Lacey,Stefano Malvolti

Expert review of vaccines（2021）

Cited13Views0WOSBibtex

Vaccines Against Leishmaniasis: Using Controlled Human Infection Models to Accelerate Development

Vivak Parkash,Paul M. Kaye,Alison M. Layton,Charles J. Lacey

Expert Review of Vaccines（2021）

Cited10Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn